Trademark Overview
On Thursday, October 31, 2024, a trademark application was filed for LENTICURE with the United States Patent and Trademark Office. The USPTO has given the LENTICURE trademark a serial number of 98830214. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, October 31, 2024. This trademark is owned by LentiCure B.V.. The LENTICURE trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical preparations and substances for the treatment of metabolic, muscular, immune system and central nervous system related diseases and disorders; Gene therapy products, namely, genetically engineered tissues for transplant purposes; Stem cells for medical purposes
Stem cell therapy services; Gene therapy services; Stem cell storage; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical services in the field of metabolic, muscular, immune system and central nervous system related diseases and disorders; Collection and preservation of human genetic resources for medical diagnosis and treatment
Gene therapy research; Stem cell research; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Research and development services in the field of medical and pharmaceutical preparations; Medical research laboratory services in the field of gene therapy; Laboratory research services relating to pharmaceuticals; Scientific, pharmaceutical and medical research and development in the field of gene modification, gene editing, gene correction, gene repair, gene modulation, cell therapy, cellular modification and gene therapy; Medical development services, namely, custom manufacture of cells for diagnostic, medical and commercial applications in relation to cell and gene therapies.
